Cargando…

Long-term virological outcome in chronic hepatitis B patients with a partial virological response to entecavir

BACKGROUND/AIMS: The clinical outcome of patients with a partial virological response (PVR) to entecavir (ETV), in particular nucloes(t)ide analogue (NA)-experienced patients, has not been thoroughly investigated. The aim of the present study was to assess long-term outcomes in NA-naive and NA-exper...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jo, Yu Jung, Kim, Kyung-Ah, Lee, June Sung, Kim, Nam-Hoon, Bae, Won Ki, Song, Tae June, Kim, Jeong Wook
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association of Internal Medicine 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4351323/ https://www.ncbi.nlm.nih.gov/pubmed/25750558 http://dx.doi.org/10.3904/kjim.2015.30.2.170

Ejemplares similares

Continuous Long-Term Entecavir Therapy in Naïve Chronic Hepatitis B Patients Showing Partial Virologic Response
por: Kwon, Dae Hun, et al.
Publicado: (2013)

Short Term Virologic Efficacies of Telbivudine versus Entecavir against Hepatitis B-Related Hepatocellular Carcinoma
por: Kim, Young Woon, et al.
Publicado: (2015)

Efficacy of prolonged entecavir monotherapy in treatment-naïve chronic hepatitis B patients exhibiting a partial virologic response to entecavir
por: Choi, Han Na, et al.
Publicado: (2015)

Virologic Response and Safety of Tenofovir Versus Entecavir in Treatment-Naïve Chronic Hepatitis B patients
por: Yu, Hyung Min, et al.
Publicado: (2015)

Is increasing the dose of Entecavir effective in partial virological responders?
por: Erturk, Ayse, et al.
Publicado: (2014)

Concomitant food intake does not affect the efficacy of entecavir in chronic hepatitis B patients with virological response: a randomized, multicenter, noninferiority trial
por: Cho, Eun Ju, et al.
Publicado: (2018)

Partial Virological Response after 2 Years of Entecavir Therapy Increases the Risk of Hepatocellular Carcinoma in Patients with Hepatitis B Virus-Associated Cirrhosis
por: Shin, Seung Kak, et al.
Publicado: (2021)

Pretreatment serum HBsAg-to-HBV DNA ratio predicts a virologic response to entecavir in chronic hepatitis B
por: Song, Joon Chang, et al.
Publicado: (2011)

Correlation Between Serum Entecavir Concentration and Virological Response in Patients with Chronic Type B Hepatitis
por: Wu, Zhengjie, et al.
Publicado: (2019)

Switching from entecavir to tenofovir alafenamide for maintaining complete virological response in chronic hepatitis B
por: Ishido, Shun, et al.
Publicado: (2023)

Hepatitis C virus: virology and life cycle
por: Kim, Chang Wook, et al.
Publicado: (2013)

Virologic breakthrough in a patient with chronic hepatitis B by combination treatment with tenofovir disoproxil fumarate and entecavir
por: Suzuki, Fumitaka, et al.
Publicado: (2014)

Association of virological breakthrough and clinical outcomes in entecavir-treated HBeAg-positive chronic hepatitis B
por: Huang, Yi-Jie, et al.
Publicado: (2019)

Antiretroviral Genotypic Resistance Mutations in HIV-1 Infected Korean Patients with Virologic Failure
por: Chin, Bum Sik, et al.
Publicado: (2009)

Durability of a sustained virologic response in patients with chronic hepatitis C treated with peginterferon and ribavirin
por: Kim, Kyung-Ah
Publicado: (2011)

Efficacy of long-term tenofovir disoproxil fumarate therapy in chronic hepatitis B patients with partial virologic response in real practice
por: Song, Jeong Eun, et al.
Publicado: (2019)

Efficacy of Lamivudine or Entecavir against Virological Rebound after Achieving HBV DNA Negativity in Chronic Hepatitis B Patients
por: Miyauchi, Tomoo, et al.
Publicado: (2013)

On-treatment HBV DNA dynamics predict virological breakthrough in entecavir-treated HBeAg-positive chronic hepatitis B
por: Huang, Yi-Jie, et al.
Publicado: (2017)

Kinetics in HBsAg after Stopping Entecavir or Tenofovir in Patients with Virological Relapse but Not Clinical Relapse
por: Tseng, Tzu-Ning, et al.
Publicado: (2022)

Comparison of the long-term efficacy between entecavir and tenofovir in treatment- naïve chronic hepatitis B patients
por: Park, Ji Won, et al.
Publicado: (2017)

Serum hepatitis B virus RNA is a predictor of HBeAg seroconversion and virological response with entecavir treatment in chronic hepatitis B patients
por: Luo, Hao, et al.
Publicado: (2019)

Prognosis of Untreated Minimally Active Chronic Hepatitis B Patients in Comparison With Virological Responders by Antivirals
por: Lee, Hye Won, et al.
Publicado: (2019)

Virology of hepatitis C virus
por: Simmonds, Peter
Publicado: (1996)

Acute pancreatitis associated with pegylated interferon-alpha-2a therapy in chronic hepatitis C
por: Choi, Jong Wook, et al.
Publicado: (2016)

Long-term real-world entecavir therapy in treatment-naïve hepatitis B patients: base-line hepatitis B virus DNA and hepatitis B surface antigen levels predict virologic response
por: Cho, Ju-Yeon, et al.
Publicado: (2017)

Virological Response and Muscular Adverse Events during Long-Term Clevudine Therapy in Chronic Hepatitis B Patients
por: Kim, Byung Kook, et al.
Publicado: (2013)

Dynamic changes of cytokine profiles and virological markers during 48 weeks of entecavir treatment for HBeAg-positive chronic hepatitis B
por: Li, Minghui, et al.
Publicado: (2022)

Platelet count is associated with sustained virological response rates in treatments for chronic hepatitis C
por: Jun, Baek Gyu, et al.
Publicado: (2019)

Non-Inferior Efficacy of Tenofovir Disoproxil to Tenofovir Disoproxil Fumarate in Virologically Suppressed Chronic Hepatitis B Patients
por: Yim, Hyung Joon, et al.
Publicado: (2022)

Virology
por: Wilkins, Yvonne Diane
Publicado: (1982)

Virology
por: Boland, G. J.
Publicado: (2017)

Virology
por: Georgiev, Vassil St.
Publicado: (2009)

Virology
por: Marschang, Rachel E.
Publicado: (2019)

Virology
por: Kanki, Phyllis J., et al.
Publicado: (2005)

Predicting Liver-Related Events Using Transient Elastography in Chronic Hepatitis C Patients with Sustained Virological Response
por: Lee, Hye Won, et al.
Publicado: (2016)

The effects of the insulin resistance index on the virologic response to entecavir in patients with HBeAg-positive chronic hepatitis B and nonalcoholic fatty liver disease
por: Zhu, Li-Yao, et al.
Publicado: (2016)

Molecular virology of hepatitis E virus
por: Ahmad, Imran, et al.
Publicado: (2011)

Hepatitis delta: virological and clinical aspects
por: Botelho-Souza, Luan Felipo, et al.
Publicado: (2017)

Immunological dynamics associated with rapid virological response during the early phase of type I interferon therapy in patients with chronic hepatitis C
por: Lee, Jae-Won, et al.
Publicado: (2017)

Virologic response is not durable after adefovir discontinuation in lamivudine-resistant chronic hepatitis B patients
por: Jung, Young Kul, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_40bheq2chtcq7d17fm2hrg4cgk